Home|Journals|Articles by Year|Audio Abstracts
 

Editorial



Involvement of private players in pharmacovigilance program of India: Data reliability will be under question

Rajiv Mahajan.




Abstract

Pharmacovigilance or Adverse Drug Reactions (ADRs) monitoring is the pharmacological science related to the collection, detection, assessment, monitoring, and prevention of adverse effects or any other drug-related problem. India is fast growing as a hub of clinical trials. This is reflected in the fact that the total number of applications received and processed at Central Drug Standard Control Organization (CDSCO) New Delhi has doubled from around 10,000 in the Year 2005 to 22,806 in Year 2009; with increase in New Drug Applications, global clinical trials, and market authorization of vaccine and biotech products from 1200, 100, and 10 in Year 2005 to 1753, 262, and 137 in the Year 2009 respectively.

Key words: Pharmacovigilance, India, Private Players






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.